Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Mckhann, D. Drachman, M. Folstein, R. Katzman, D. Price, E. Stadlan (1984)
Clinical diagnosis of Alzheimer's diseaseNeurology, 34
Veronica Hirsch-Reinshagen, L. Maia, Braydon Burgess, J. Blain, K. Naus, Sean McIsaac, Pamela Parkinson, Jennifer Chan, Gavin Tansley, M. Hayden, J. Poirier, W. Nostrand, C. Wellington (2005)
The Absence of ABCA1 Decreases Soluble ApoE Levels but Does Not Diminish Amyloid Deposition in Two Murine Models of Alzheimer Disease*Journal of Biological Chemistry, 280
(1988)
Utility Programs for Analysis of Genetic Linkage, Program HWE
G. Schmitz, W. Kaminski, E. Orso (2000)
ABC transporters in cellular lipid traffickingCurrent Opinion in Lipidology, 11
A. Koudinov, T. Berezov, N. Koudinova (2002)
Cholesterol and Alzheimer's disease: is there a link?Neurology, 58 7
B. Wolozin, Wendy Kellman, Paul Ruosseau, G. Celesia, G. Siegel (2000)
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.Archives of neurology, 57 10
H. Katzov, K. Chalmers, J. Palmgren, N. Andreasen, B. Johansson, N. Cairns, M. Gatz, G. Wilcock, S. Love, N. Pedersen, A. Brookes, K. Blennow, P. Kehoe, J. Prince (2004)
Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to β‐amyloid metabolismHuman Mutation, 23
M. Wollmer, J. Streffer, D. Lütjohann, M. Tsolaki, Vassiliki Iakovidou, T. Hegi, T. Pasch, H. Jung, K. Bergmann, R. Nitsch, C. Hock, A. Papassotiropoulos (2003)
ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer’s diseaseNeurobiology of Aging, 24
M. Kivipelto, E. Helkala, M. Laakso, T. Hänninen, M. Hallikainen, K. Alhainen, H. Soininen, J. Tuomilehto, A. Nissinen (2001)
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based studyBMJ, 322
C. Schweiger (2001)
[Statins and the risk of dementia].Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2 3
Y. Li, L. Chu, Y.Q. Chen, B. Cheung, R. Leung, P. Yik, K. Ng, W. Mak, D. Jin, P. George-Hyslop, Y. Song (2006)
Intron 2 (T/C) CYP46 Polymorphism Is Associated with Alzheimer’s Disease in Chinese PatientsDementia and Geriatric Cognitive Disorders, 22
R. Frikke-Schmidt, B. Nordestgaard, G. Jensen, A. Tybjaerg-hansen (2004)
Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population.The Journal of clinical investigation, 114 9
B. Wolozin (2003)
Cyp46 (24S-cholesterol hydroxylase): a genetic risk factor for Alzheimer disease.Archives of neurology, 60 1
B. Wolozin (2001)
A fluid connection: cholesterol and Abeta.Proceedings of the National Academy of Sciences of the United States of America, 98 10
A. Brooks-Wilson, M. Marcil, S. Clee, Lin-hua Zhang, K. Roomp, Marjel Dam, Lu Yu, C. Brewer, J. Collins, H. Molhuizen, O. Loubser, B.F. Ouelette, K. Fichter, K. Ashbourne-Excoffon, C. Sensen, S. Scherer, Stephanie Mott, M. Denis, D. Martindale, J. Frohlich, K. Morgan, B. Koop, S. Pimstone, J. Kastelein, J. Genest, M. Hayden (1999)
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiencyNature Genetics, 22
J. Barrett, B. Fry, J. Maller, M. Daly (2005)
Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 21 2
N. Shibata, T. Kawarai, Joseph Lee, Hye-Seung Lee, Eri Shibata, C. Sato, Yan Liang, R. Duara, R. Mayeux, P. George-Hyslop, E. Rogaeva (2006)
Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer's diseaseNeuroscience Letters, 391
The location of SNP17 (rs2297404) and the branch site in intron 33 of ABCA1 gene
M. Kenward (2007)
An Introduction to the Bootstrap
M. Bodzioch, E. Orso, J. Klucken, T. Langmann, A. Böttcher, Wendy Diederich, W. Drobnik, S. Barlage, C. Büchler, M. Porsch-Özçürümez, W. Kaminski, H. Hahmann, K. Oette, G. Rothe, C. Aslanidis, K. Lackner, G. Schmitz (1999)
The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier diseaseNature Genetics, 22
Yonghong Li, K. Tacey, Lisa Doil, Ryan Luchene, Veronica Garcia, C. Rowland, S. Schrodi, Diane Leong, Kit Lau, J. Catanese, J. Sninsky, P. Nowotny, P. Holmans, J. Hardy, J. Powell, S. Lovestone, L. Thal, M. Owen, Julie Williams, A. Goate, A. Grupe (2004)
Association of ABCA1 with late-onset Alzheimer’s disease is not observed in a case-control studyNeuroscience Letters, 366
You-qiang Song, E. Rogaeva, S. Premkumar, Nicholas Brindle, T. Kawarai, A. Orlacchio, Gang Yu, G. Lévesque, Masaki Nishimura, M. Ikeda, Y. Pei, C. O'Toole, R. Duara, W. Barker, S. Sorbi, M. Freedman, L. Farrer, P. George-Hyslop (1998)
Absence of association between Alzheimer disease and the −491 regulatory region polymorphism of APOENeuroscience Letters, 250
K. Abildayeva, P. Jansen, Veronica Hirsch-Reinshagen, V. Bloks, A. Bakker, F. Ramaekers, J. Vente, A. Groen, C. Wellington, F. Kuipers, M. Mulder (2006)
24(S)-Hydroxycholesterol Participates in a Liver X Receptor-controlled Pathway in Astrocytes That Regulates Apolipoprotein E-mediated Cholesterol Efflux*Journal of Biological Chemistry, 281
Suzanne Wahrle, Hong Jiang, Maia Parsadanian, R. Hartman, K. Bales, S. Paul, D. Holtzman (2005)
Deletion of Abca1 Increases Aβ Deposition in the PDAPP Transgenic Mouse Model of Alzheimer Disease*Journal of Biological Chemistry, 280
B. Neale, P. Sham (2004)
The future of association studies: gene-based analysis and replication.American journal of human genetics, 75 3
R. Koldamova, M. Staufenbiel, I. Lefterov (2005)
Lack of ABCA1 Considerably Decreases Brain ApoE Level and Increases Amyloid Deposition in APP23 Mice*Journal of Biological Chemistry, 280
L. Chu, Edmond Ma, Kevin Lam, M. Chan, D. Lee (2005)
Increased Alpha 7 Nicotinic Acetylcholine Receptor Protein Levels in Alzheimer’s Disease PatientsDementia and Geriatric Cognitive Disorders, 19
V. Ramensky, P. Bork, S. Sunyaev (2002)
Human non-synonymous SNPs: server and survey.Nucleic acids research, 30 17
B. Wolozin (2001)
A fluid connection: Cholesterol and AβProceedings of the National Academy of Sciences of the United States of America, 98
K. Chiu (2002)
CLINICAL FEATURES OF ALZHEIMER ’ S DISEASE IN A REGIONAL MEMORY CLINIC IN HONG KONG
M. Fitzgerald, A. Morris, J. Rhee, L. Andersson, A. Mendez, M. Freeman (2002)
Naturally Occurring Mutations in the Largest Extracellular Loops of ABCA1 Can Disrupt Its Direct Interaction with Apolipoprotein A-I*The Journal of Biological Chemistry, 277
B. Wolozin (2004)
Cholesterol and the Biology of Alzheimer's DiseaseNeuron, 41
Recent genetic studies have shown that variants of the ATP‐binding cassette transporter A1, ABCA1, may be implicated in the pathogenesis of Alzheimer's disease (AD). In this case‐control study, a panel of 19 single nucleotide polymorphisms (SNP) (including three amino‐acid‐coding SNPs used for replication of previous work, and 16 newly selected intronic tag SNPs) was genotyped. Nominally significant single marker P‐values were observed in four SNPs, with the highest score of 0.003 for rs2297404 (OR = 1.88, 95%CI 1.23–2.87). In addition, six distinct linkage disequilibrium (LD) blocks were detected. LD block1 harbored three nominally significant SNPs (rs2297404, rs2230808, and rs2020927), and showed a different haplotype structure in the affected and unaffected groups. Of the four haplotypes identified, haplotype2 (CAC) was more prevalent in the disease group (0.323 in AD vs. 0.202 in control); while haplotype1 (TGG) was over‐represented in the healthy controls (0.595 in control vs. 0.493 in AD), indicating disease risk conferring possibility of haplotype2. After doubling the sample size, the three nominally significant SNPs were still significantly associated with AD. Although coding SNP (rs2230808) was confirmed to have a significant association with AD, prediction of the effects of an amino acid substitution SNP rs2230808 (R1587K) on the three‐dimensional structure and function of the ABCA1 protein using PolyPhen program revealed that it is unlikely to be functionally significant. However, the adjacent rs2297404 in the same LD block is potentially functionally significant because of its position in the immediate vicinity of a splicing branch site. Further functional analysis of this polymorphism should be a high priority. © 2007 Wiley‐Liss, Inc.
American Journal of Medical Genetics part B – Wiley
Published: Dec 5, 2007
Keywords: Alzheimer's disease; ABCA1 ; haplotype; single nucleotide polymorphisms (SNP); association; case‐control
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.